Improvement in Vision Parameters for Participants Treated With Alternative Therapies in a 3-day Program

Transcription

1 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com ORIGINAL RESEARCH Improvement in Vision Prmeters for Prticipnts Treted With Alterntive Therpies in -dy Progrm Edwrd C. Kondrot, MD, MD(H), CCH, DHt ABSTRACT Context Eye conditions tht re considered progressive nd degenertive nd for which the custion is generlly poorly understood or not understood within conventionl medicine cn respond to nturl therpeutic interventions tht result in rrest nd/or improvement of morbidity, with enhnced functionl results. Becuse mny of the treted conditions re ge relted, dely of disese progression for 5 or even 1 y cn men n dditionl decde of independence for seniors. The 11 included oculr conditions re ordinrily considered incurble by ny method except surgery nd, even with surgery, the outcomes cn be vrible nd/or trnsient. Objective The reserch intended to demonstrte the effectiveness of lterntive modlities intrvenous (IV) nutrition, oxidtive therpy, microcurrent stimultion, nd syntonic light therpy in improving vision in chronic eye conditions, even when dministered for short period. Design The study ws retrospective, open-lbel, singlegroup design. All prticipnts in the -d conference during the period covered were selected. Setting The setting ws ophthlmologist Edwrd Kondrot s Heling the Eye nd Wellness Center ner Tmp, FL, USA. Prticipnts The prticipnts in this study were ll ptients ttending 1 of 11 CAM tretment events t the uthor s center within y. Ech session lsted d nd the number of prticipnts in ech session rnged from 5-15 (men = 1). The cohort numbered 15 ptients who were dignosed with 1 of 11 types of eye disese. Seventy-eight percent of the ptients hd either ge-relted mculr degenertion (ARMD) or glucom, which, tken together, re the leding cuse of blindness in persons >65 y. Intervention Ech of lterntive modlities ws provided t lest once to ech prticipnt: (1) IV nutrition, () oxidtive therpy, () microcurrent stimultion, nd () syntonic light therpy. On the first dy, detiled tretment pln for ech prticipnt ws developed. Ech dy consisted of therpeutic eye progrms, stress reduction progrm, nd detoxifiction progrm. Also included were dily lectures nd instructions on the methods nd use of the equipment. Outcome Mesures To mesure outcomes, chnges from bseline were documented through comprison with postprogrm results. Pre- nd postprogrm testing included the following mesures: (1) Erly Tretment Dibetic Retinopthy Study (ETDRS) eye chrt; () Lighthouse Letter Contrst Sensitivity test; () cmpimetry; () pursuits, sccde, nd fixtion tests; (5) pupillry exmintion; (6) externl exmintion; (7) exmintion of the nterior segment; (8) introculrpressure test; nd (9) dilted exmintion. Additionl tests, if necessry, included (1) oculr coherence tomogrphy, () infrred thermogrphy, () 6-hour urine collection for hevy-metl toxicity, nd () nocturnl oximetry. Results All prticipnts remined in the study for the durtion of the progrm. Following the dministrtion of the protocol, significnt improvement in cuity, contrst, nd visul field resulted in the mjority of prticipnts. None of the interventions ws toxic or pinful, nd ll likely contributed to n improved, overll helth sttus for prticipnts. Conclusions These tretment protocols should be considered prt of tretment progrm for ll oculr disese processes. Eye helth needs to be repositioned within n ssessment of generl helth with the understnding tht, with the exception of congenitl disorders or ccidents, vision decline represents generl diminishment in overll helth nd results directly from toxicity from both externl sources such s ir nd wter, nd the internl ccumultion of toxic metls; poor nutrition; nd other life exposures nd hbits. Long-term follow-up studies re now in process. (Altern Ther Helth Med. 15;1(6):-5.) ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 Kondrot Vision Prmeters nd Alterntive Therpies

2 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com Edwrd C. Kondrot, MD, MD(H), CCH, DHt, is the clinic director of integrtive medicine t the Americn Medicl College of Homeopthy in Phoenix, Arizon. Corresponding uthor: Edwrd C. Kondrot, MD, MD(H), CCH, DHt E-mil ddress: info@helingtheeye.com Eye conditions tht re considered progressive nd degenertive nd for which the custion is generlly poorly understood or not understood t ll cn respond to nturl therpeutic interventions tht result in rrest nd/or improvement of morbidity, with enhnced functionl results. 1 Becuse mny of the treted conditions re ge relted, dely of disese progression for 5 or even 1 yers cn men n dditionl decde of independence for seniors. The conditions re (1) ge-relted mculr degenertion (ARMD), the dry type; () glucom; () ARMD, the wet type; () mculr hole, wrinkling, pucker; (5) Strgrdt s disese; (6) ctrcts; (7) ischemic optic nerve disese; (8) retinitis pigmentos (RP); (9) dibetic retinopthy; (1) histoplsmosis scrring; nd (11) cone dystrophy. ARMD, Dry Type. ARMD dry is the most common cuse of irreversible blindness in people older thn 65 yers. It is slow, progressive disese tht ffects the centrl re of the retin clled the mcul. This is the loction in the retin responsible for centrl vision nd the most detil. The dry or reolr type consists of degenertion of the retinl pigment cells, resulting in drusen smll wrt-like growth nd hyper- nd hypopigmented res in the retin, with loss of rods nd cones nd generlized trophy. The exct cuse of ARMD is not known, but the erliest chnges occur in the choroid the vsculr lyer of the eye nd in the pigmented retinl epithelium. These chnges begin s thickening of Bruch s membrne, which is the lyer of the choroid next to the retin. These thickened res become rised nd hve the ppernce of wrts. These chnges produce loss of pigment nd cell deth of the functioning lyers of the retin. The condition eventully leds to fluid ccumultion, hemorrhge, nd scr tissue. Loss of centrl vision occurs, but this rrely produces totl blindness becuse the peripherl vision is preserved. The disese commonly occurs in individuls older thn 65 yers, but severl hereditry conditions cn led to this disorder t much erlier ge. Ptients usully complin of blurred vision nd difficulty with close work. They cn lso develop wvy lines nd distortion of liner trgets. They experience loss of color sense nd the development of scotoms, smll res of blindness. Glucom. This disese occurs when the optic nerve of the eye begins to lose its function. The optic nerve is the trnsmitter of visul imges from the eye to the brin. In the erly stges, dmge of the nerve results in loss of peripherl vision; in lter stges, blindness cn result. Abnormlity in the circultion of the optic nerve ppers to be the reson for dmge to the optic nerve. Elevted introculr pressure is believed to be the min contributing fctor, lthough some ptients with glucom hve low or norml introculr pressure. Other fctors tht mke the nerve more susceptible to dmge re rteriosclerosis nd dibetes mellitus. ARMD, Wet Type. The wet or exudtive type of mculr degenertion presents s vsculr lekge with exudtes nd detchment of the retin with loss of vision. A smll percentge of the cses cn be treted successfully with the rgon lser. Mculr Hole, Wrinkling, Pucker. A mculr hole is smll brek in the mcul, locted in the center of the eye s light-sensitive retin. A mculr hole cn cuse blurred nd distorted centrl vision. Mculr holes re relted to ging nd usully occur in people older thn 6 yers. The size of the hole nd its loction on the retin determine how much it will ffect person s vision. When stge III mculr hole develops, most centrl nd detiled vision cn be lost. If left untreted, mculr hole cn led to detched retin, sight-thretening condition. Strgrdt s Disese. This disese is n inherited form of juvenile mculr degenertion tht cuses progressive vision loss, usully to the point of legl blindness. The progression usully strts between the ges of 6 yers nd 1 yers, nd it plteus shortly fter rpid reduction in visul cuity. Severl genes re ssocited with the disorder. Symptoms typiclly develop by yers of ge nd include wvy vision, blind spots, blurriness, impired color vision, nd difficulty dpting to dim lighting. Ctrcts. Ctrcts re due to clouding, hrdness, nd loss of elsticity tht occur in the humn lens. Ctrcts re ssocited with generl rteriosclerotic chnges, dibetes, sun exposure, trum, nd poor nutrition. More thn 5% of people older thn 6 yers will develop ctrcts. With ge, chnges in the protein of the lens develop. Oxidtive rections develop, which form bnorml disulfide nd other covlent linkges. This chnge cuses the lens fibers to lose their trnsprency. Ionizing rdition hs very high, ctrctproducing effect, nd the lens is its most sensitive trget within the dult eye. Its dmge is dose relted nd cumultive. The sources of electromgnetic rdition energy most importnt in dmge to the lens re ionizing rdition X-rys, gmm rys nd neutrons, emission of infrred or ultrviolet rys from vrious hot bodies, nd microwves. Copper, iron, nd mercury poisoning cn led to the development of ctrcts. Ischemic Optic Nerve. The optic nerve is mde up of 1 million, tiny, delicte nerve fibers tht re like wires. Mny blood vessels nourish the optic nerve with oxygen nd nutrition. Vision ctully tkes plce in the brin when the messges from the eye trvel to the brin long the optic nerve; however, the nerve must be helthy to trnsmit these messges. Ischemic optic-nerve conditions occur due to dmge to the optic nerve from insufficient blood supply. Retinitis Pigmentos. RP is n inherited, degenertive eye disese tht cuses severe vision impirment nd often blindness. The progress of RP is not consistent. Some people exhibit symptoms from infncy; others my not notice Kondrot Vision Prmeters nd Alterntive Therpies ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6

3 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com symptoms until lter in life. A form of retinl dystrophy, RP is cused by bnormlities of the photoreceptors (rods nd cones) or the retinl pigment epithelium (RPE) of the retin, leding to progressive sight loss. Affected individuls my experience defective light-to-drk nd drk-to-light dpttion (ie, night blindness) s the result of the degenertion of the peripherl visul field. Sometimes, centrl vision is lost first, cusing the person to look sidelong t objects. Dibetic Retinopthy. Dibetic retinopthy is dmge to the retin cused by complictions of dibetes, which cn eventully led to blindness. It is n oculr mnifesttion of dibetes, systemic disese. The condition ffects up to 8% of ll ptients who hve hd dibetes for 1 yers or longer. Histoplsmosis Scrring. Scientists believe tht Histoplsm cpsultum (ie, spores spred from the lungs to the eye) lodge in the choroid, lyer of blood vessels tht provides blood nd nutrients to the retin. The condition develops when frgile, bnorml blood vessels grow underneth the retin. These bnorml blood vessels form lesion known s choroidl neovsculriztion. If left untreted, the lesion cn turn into scr tissue nd replce the norml retinl tissue in the mcul. The mcul is the centrl prt of the retin tht provides the shrp, centrl vision. When this scr tissue forms, visul messges from the retin to the brin re ffected, nd vision loss results. Cone Dystrophy. Cone dystrophy is n inherited oculr disorder chrcterized by the loss of cone cells, the photoreceptors responsible for both centrl nd color vision. The most common symptoms of cone dystrophy re vision loss, with the ge of onset rnging from the lte teens to the 6s; sensitivity to bright lights; nd poor color vision. Therefore, ptients see more t dusk. Visul cuity usully deteriortes grdully, but it cn deteriorte rpidly. Color vision testing revels mny errors on both red-green nd blue-yellow pltes. The eye diseses ddressed here re often not responsive to trditionl tretments, nd some ptients wish to void surgery or the side effects of mediction. METHODS Prticipnts Ptients pplied to the progrm bsed on their interest in prticipting in -dy Heling the Eye progrm tht ws conducted t the investigtor s retret setting, The Heling the Eye Wellness Center (ner Tmp, FL, USA). The Wellness Center is fully functioning, orgnic rnch with grden nd frm nimls. The center encourges exercise, nd the fcilities include bsketbll court, swimming pool, hot tub, weight room, nd infrred sun, together with mny miles of sndy rod for jogging. On-site, hotel-like ccommodtions re provided together with orgnic mels tht re prepred on site. Ech prticipnt forwrded tests nd dignostic informtion prior to being ccepted into the progrm, nd those results were verified t the strt of the progrm. The cost of the progrm ws $ for the -dy tretment progrm, excluding trvel expenses. There re dditionl chrges for home use of Microcurrent mchine, postprogrm ($5), nd for follow-up cre for 1 yer. A smll number of prticipnts were the investigtor s ptients; others were referred by physicins or were selfreferred. At the time of the study, the -dy progrms hd been conducted for more thn 1 yers, with the curriculum evolving to keep pce with reserch nd the results of the investigtor s studies. The study s prticipnts were selected to prticipte s pying prticipnts in the -dy progrm fter meeting the following criteri: (1) they hd eye disese tht hd not been responsive to trditionl tretments or () they wished to void surgery or the side effects of mediction. All prticipnts signed detiled informed consent forms. Prticipnts rnged in ge from 15 to 95 yers; 5% were femle, nd 8% were mle. Forty-six percent resided in Cliforni, Arizon, nd Florid, with the remining coming from 11 dditionl sttes. One prticipnt lived in Mexico. Procedures The study used -dy intervention protocol. On the first dy of the progrm, the center obtined the following informtion for cretion of detiled tretment pln for ech prticipnt to llow the person to regin vision. Detiled Eye History. This provided informtion relted to the underlying cuse of the eye problem. Medicl History. This provided informtion bout other physicl problems tht potentilly hd contributed to the eye disese. List of Medictions. This ws list of prticipnt s current medictions; every medicine potentilly cn be toxic to the eye. Dietry History. Nutritionl eduction is n integrl component of the progrm. Ech prticipnt receives zinc tste test. This simple, -minute test mesures the intrcellulr levels of zinc. Zinc is key nutrient, not only for the eye but lso for every enzymtic function in the body. A deficiency of zinc is red flg tht other nutritionl deficiencies exist. Only orgnic food tht ws not geneticlly modified (ie, non-gmo food) ws served during the -dy progrm, with much of it being rw. Following the progrm, prticipnts were encourged to continue 7/ diet, with 7% of food to be orgnic nd consumed rw, nd the other % lso to be orgnic but llowed to be cooked. Evlution of Life Stressors. This informtion llowed the center to develop progrm to reduce those stressors. Investigtion of Hevy-metl Exposure. Hevy-metl toxicity contributes to ll degenertive eye diseses. Zyto Energetic Anlysis. This test is used to mesure fluctutions in electricl conductivity of the skin. Fluctutions in electricl conductivity were mesured during tretments, such s when the microcurrent nd light therpy were pplied. The responses helped determine prticipnts physicl preferences regrding the interventions being ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 Kondrot Vision Prmeters nd Alterntive Therpies

4 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com considered nd cted s guides in specifiction of tretment protocols. Ech dy consisted of therpeutic eye progrms: (1) stress reduction progrm nd () detoxifiction progrm. Also included were dily lectures nd instructions on the methods nd use of the equipment. The lecture schedule included the following informtion: Dy 1. Provided informtion bout diet, nutrition, hydrtion, nd cretion of blnce in the utonomic nervous system. A blnced utonomic nervous system hs been shown to contribute to reduced symptomtology in eye disese. Dy. Homeopthy nd microcurrent therpy were initited. Homeopthic remedies were prescribed for but not tken by prticipnts until fter the -dy workshop. It is the uthor s intention to report on the effectiveness of homeopthic tretment for chronic eye conditions in future publiction. Dy. Provided instruction on light therpy nd eye exercises. Outcome Mesures To mesure outcomes, chnges from bseline were documented through comprison with postprogrm results. Pre- nd postprogrm testing included: Erly Tretment Dibetic Retinopthy Study Eye Chrt. The Erly Tretment Dibetic Retinopthy Study (ETDRS) eye chrt is test tht mesures cuity nd hs been ccepted nd pproved in studies sponsored by the Ntionl Eye Institute nd the US Food nd Drug Administrtion (FDA). Ech line on the chrt hs 5 letters, nd the chrt hs totl of 1 lines or 7 letters. Lighthouse Letter Contrst Sensitivity Test. This test mesures the bility to see letters of incresingly lighter contrst. Filure to perceive lighter contrst is relted to toxicity nd hevy-metl poisoning. Cmpimetry. Cmpimetry is one wy to test the visul field systemticlly. It is used for testing centrl fields for white, blue, green, nd red nd lso is used in syntonics to ssess subtle chnges in wreness nd visul fields. This test mesures the bility to perceive motion. Pursuits, Sccde, nd Fixtion Tests. These tests mesure bsic visul functions tht re essentil to good vision. They relte to the eye s bility to follow movement, to chnge focl point, nd to fixte on n object of interest. Pupillry Exmintion. The pupil reflects the utonomic nervous system, nd subtle imblnces in this system cn be detected through exmintion. Externl Exmintion. This test requires creful exmintion of the outer structure of the eye, including the lids, corne, conjunctiv, nd ter film. The outer lyer protects the delicte inner prts of the eye, nd the ter film lubrictes the corne nd supplies nutrients nd oxygen. Exmintion of the Anterior Segment. This re is inspected for signs of inflmmtion nd toxicity. The lens, or the prt of the eye tht focuses light into the eye, is inspected for signs of ctrcts nd toxicity. Introculr-pressure Test. This test is importnt in detection of glucom. Prticipnts pressures were monitored throughout the -dy progrm. Dilted Exmintion. The inside of the eye is the only plce in the body where blood vessels nd neurologicl tissue cn be exmined without surgery. The vsculture, retin, mcul, nd optic nerve were exmined for disese. Specilized Testing Avilble During the -dy Progrm. Depending on prticipnt s condition nd the results of the bove testing, the following tests were lso vilble during the -dy progrm: Oculr Coherence Tomogrphy. This sophisticted test mesures cross-section of the retin under high mgnifiction. It offers the opportunity to exmine ll 1 lyers of the retin to locte the res of disese precisely. Infrred Thermogrphy. This test mesures temperture differences on the surfce of the fce. It is very ccurte test for detection of bnormlities of the orbits, sinuses, nd teeth tht might be contributing to eye problems. While not specific to mesuring vision or eye pthology, the following tests re included s wy of mesuring possible contributing fctors to the prticipnts eye condition. Six-hour Urine Collection to Test For Hevy-Metl Toxicity. This test is the gold stndrd to determine the levels of toxic minerls stored in tissue. At the end of the -dy progrm, ptients were given the test kit nd were requested to complete it t home nd send the smples to the lb for results. The investigtor then discussed the findings during follow-up telephone evlution tht occurred 1 month fter the -dy session. Almost ll prticipnts tested positive for hevy-metl toxicity nd were dvised to undergo cheltion therpy fter the workshop. Nocturnl Oximetry. This test mesures oxygen sturtion t night. Mny ptients, becuse of obstructive irwy disese (sleep pne), hve low levels of oxygen t night, which cn contribute to the development of eye disese, nd if not treted, cn ffect the success of eye tretments. Interventions The intervention in the -dy progrm begn with tretments tht blnced the utonomic nervous system nd neuroendocrine functions nd ctivities to reduce stress. Emphsis ws plced on developing customized progrm for ech prticipnt s eye problem. This progrm ws reclibrted for ech prticipnt during the dys, depending on outcomes nd response to tretment from mesurements tken intermittently. The lterntive modlities were provided t lest once to ech prticipnt: (1) intrvenous (IV) nutrition, () oxidtive therpy, () microcurrent stimultion, nd () syntonic light therpy. IV Nutrition Myer s Cocktil. This specilized intrvenous vitmin mixture ws designed to provide key vitmins nd minerls to support the eye nd visul function.,5,6 Kondrot Vision Prmeters nd Alterntive Therpies ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 5

5 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com It ws suggested tht ll ptients receive this mixture, prticulrly if they were deficient in zinc. It lso ws suggested tht ll ptients in the progrm receive Myer s cocktil once per month t their home loctions until nutritionl levels were t n optimum level. The cocktil tht the Wellness Center offers is tilored to provide nutrients known to be supportive of good vision: (1) scorbic cid, 5 mg/ml, 1 cc; () pyridoxine, 1 mg/ml, cc; () hydroxocoblmin 1, μg/ml, 1 cc; () B complex 1, 1 cc; (5) clcium gluconte 1%, 1 cc; (6) dexpnthenol, 5 mg/ml, 1 cc; (7) mgnesium chloride, mg/ml, 1 cc; (8) multitrce-5 concentrte, 1 cc; (9) selenium, μg/ml, 5 cc; (1) turine, 5 mg/ml, cc; (11) zinc, 1 mg/ml, 5 cc; (1) lidocine %, 5 cc; (1) sterile wter, cc; nd (1) folic cid, 1 mg. Oxidtive Therpy. Oxidtive therpies such s ozone therpy, ultrviolet blood irrdition therpy, nd intrvenous hydrogen peroxide therpy cn be beneficil for treting wide rnge of conditions rnging from virl nd fungl infections to joint pin nd rthritis. 7 Oxidtive therpies work by stimulting the immune system, enhncing mitochondril processes, nd fcilitting heling with virtully no side effects. Some reserchers believe tht this therpy cn be very helpful in the tretment of mculr degenertion nd glucom nd other eye disorders. 8. Typiclly to tretments re necessry, lthough benefits cn be experienced fter 1 or tretments. Ech ptient receives minimum of oxidtive IV therpies during the progrm. Severl oxidtive modlities cn be done in the home nd prticipnts were trined to continue them fter the -dy session nd given the equipment needed to do so. Ozone therpy is type of oxidtive therpy brekthrough tretment tht is ble to detoxify s it hels. It uses highly rective oxygen gs, which stimultes regenertion nd heling. It is used to tret wide rnge of chronic conditions, including mculr degenertion. 9 The progrm offered ozone therpy in severl wys: (1) intrvenously, clled uto hemotherpy, where smll mount of blood is mixed with the ozone nd then injected into the body; nd () s eye drops, to help stimulte the heling of the eye. Hydrogen peroxide therpy ws lso provided to some prticipnts in the progrm. This type of oxidtive therpy is given directly into the blood strem through slow IV drip nd hs the sme beneficil results s other types of oxidtive therpies Microcurrent Stimultion Therpy. Microcurrent stimultion (MCS) therpy is well-estblished therpy tht improves blood flow, stimultes cellulr ctivity, reduces scr tissue nd inflmmtion, nd helps blnce the utonomic nervous system. 1 It ws delivered to the eye vi specilly designed glove tht is used to stimulte the periorbitl tissues. This device is the result of design refinement in the course of severl yers. The current is clibrted to respond specificlly to the involved tissues nd the condition being treted. The mechnism of ction is believed to be fold: improving blood flow, stimulting cellulr ctivity, nd reducing inflmmtion nd scr tissue. Ptients with glucom hve compromised optic nerve. Elevtions in pressure cn cuse the blood flow to the optic nerve to be reduced, resulting in dmge to the nerve nd loss of vision. Reserch evidence suggests tht microcurrent hs protective effect on the optic nerve. 11 MCS cn be beneficil to ptients with glucom becuse it helps increse blood flow nd stimultes cellulr ctivity, nd now evidence suggests neuroprotective effect. MCS cn lower the introculr pressure, which is observed in ptients fter MCS tretment. 1 MCS is very effective in treting most eye diseses, including mculr degenertion, glucom, ctrcts, inflmmtion, nd dry eyes. The flow of current from cell to cell nd within cells promotes repir nd regenertion of tissues. 1,1 All ptients who prticipted in the -dy workshop were provided microcurrent devices, clibrted to their specific eye diseses, nd were instructed to use them t home to continue vision improvement. Syntonic Light Therpy. Syntonics, or optometric phototherpy, is the brnch of oculr science deling with the ppliction of selected light frequencies through the eyes. It hs been used cliniclly for more thn 7 yers in the field of optometry with continued success in the tretment of visul dysfunctions, including strbismus (eye turns), mblyopi (lzy eye), focusing nd convergence problems, lerning disorders, nd the fter-effects of stress nd trum. 15 In recent yers, syntonics hs been shown to be effective in the tretment of brin injuries nd emotionl disorders. A specific wvelength of light is selected for ech person to help reblnce their prticulr imblnce. Reserch is ongoing, but dt indicte certin frequencies of blue-green light cn improve the vision in ptients with mculr degenertion nd certin frequencies of green light cn lower the pressures in ptients with glucom. 16 Ech color cn hve myrid of frequencies, nd the tsk is to identify the frequency tht best resontes with the eye, stimultes retinl function, nd blnces the utonomic nervous system. Ech prticipnt received light-therpy tretments per dy. RESULTS Tble 1 shows the number of ptients ffected by ech of the 11 eye diseses s well s the totl number of eyes ffected. Some ptients hd disese in only 1 eye, nd some ptients hd more thn 1 disese. Sixty-nine percent of the study s prticipnts hd improvement of t lest 1 line (ie, 5 letters) in cuity, nd 6% hd improvement of t lest 1 line in contrst (Tble ; Figures 1,, nd ). One line of improvement is significnt chnge tht is noticeble to ptients nd improves their levels of dily functioning. Typiclly when spectcle mesurement improves the cuity by 1 line, ptient will be dvised to get new pir of glsses. Most ophthlmic studies gree tht 5-letter or 1-line improvement is very significnt nd tht mechnism tht produces this visul chnge deserves more reserch. 6 ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 Kondrot Vision Prmeters nd Alterntive Therpies

6 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com Tble 1. Oculr Conditions, Number of Ptients, nd Number of Eye Disese Number of Ptients Number of ARMD-Dry 7 1 Glucom 9 58 ARMD-Wet Mculr hole, mculr 9 1 wrinkling, pucker Strgrdt s disese 6 Ctrcts 6 1 Ischemic optic nerve disese 6 Retinitis pigmentos 8 Dibetic retinopthy 6 Histoplsmosis scrring Cone dystrophy 1 Totl 15 9 Abbrevition: ARMD, ge-relted mculr degenertion. Some ptients hd disese in only 1 eye; some ptients hd >1 disese. Tble. Summry Results of A ll 15 Ptients or 9 Treted Acuity Improvement Number of % lines (1 letters) 15% >1 line (5 letters) 158 5% >1- letters 66 % No chnge 8% Contrst Improvement Number of % >5 letters 1 6% >1- letters 151 5% No chnge 5 1% Visul Field Expnsion Number of % Mrked % Moderte 75 6% Miniml 19 6% No chnge 1 11% Figure 1. Summry results for cuity improvement lines (1 letters) line (5 letters) 1- letters No chnge Figure. Summry results for contrst improvement. Figure. Summry results for visul field expnsion letters 1- letters No chnge 19 1 Mrked Moderte Miniml No chnge Some ptients hd disese in only 1 eye; some ptients hd more thn 1 disese. Kondrot Vision Prmeters nd Alterntive Therpies ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 7

7 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com ARMD, DRY TYPE Tble. Results: ARMD Dry,b Figure. ARMD dry: results for cuity improvement. Acuity Improvement Number of 6 > lines 1- lines 5 <1 line 5 No chnge 15 Contrst Improvement Number of >6 letters 5 15 No chnge <1 line lines Abbrevition: ARMD, ge-relted mculr degenertion. lines -5 letters 8 1- letters 5 No chnge 1 Figure 5. ARMD dry: results for contrst improvement. 6 Visul Field Expnsion Number of Mrked 76 Moderte 1 No chnge or miniml Abbrevition: ARMD, ge-relted mculr degenertion. n = 7 ptients, 1 eyes. b The verge improvement of cuity ws 5.5 letters nd the verge improvement of contrst ws.8 letters. 1 No chnge 5 <1 line 1- lines 8 5 lines Abbrevition: ARMD, ge-relted mculr degenertion. Figure 6. ARMD dry: results for visul field expnsion Mrked Moderte No chnge or miniml Abbrevition: ARMD, ge-relted mculr degenertion. 1 8 ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 Kondrot Vision Prmeters nd Alterntive Therpies

8 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com GLAUCOMA Tble. Results: Glucom,b Figure 7. Glucom: results for cuity improvement. Acuity Improvement Number of lines 1 1- lines 6 <1 line 16 No chnge lines 1- lines <1 line No chnge Contrst Improvement Number of Figure 8. Glucom: results for contrst improvement. >6 letters 17-5 letters 1 1- letters 17 No chnge 1 Visul Field Expnsion: Number of > 6 letters -5 letters 1- letters No chnge Mrked 7 Moderte 1 No chnge or miniml 7 Pressure Lowering Number of >5 mm Hg mm Hg 7 No chnge 11 c Increse in pressure 7 c Figure 9. Glucom: results for visul field expnsion Mrked Moderte No chnge or miniml Figure 1. Glucom: results for pressure lowered. 1 7 n = 9 ptients, 58 eyes. b The verge chnge in cuity ws 6 letters; the verge chnge in contrst ws.6 letters; nd the verge drop in pressure ws.8 mm Hg. c The mjority of these ptients stopped their eye drops; therefore, the pressure elevtion or lck of response could be due to stopping mediction >5 mm Hg lowering mm Hg lowering 16 No chnge 7 Increse in pressure Kondrot Vision Prmeters nd Alterntive Therpies ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 9

9 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com ARMD, WET TYPE Tble 5. Results: ARMD Wet,b Figure 11. ARMD wet: results for cuity improvement. Acuity Improvement Number of lines 8 1- lines 11 <1 line No chnge lines 1- lines <1 line No chnge Contrst Improvement Number of >6 letters 11-5 letters 9 Abbrevition: ARMD, ge-relted mculr degenertion. Figure 1. ARMD wet: results for contrst improvement. 1- letters 1 No chnge 7 Visul Field Expnsion Number of Mrked 6 Moderte 8 No chnge or miniml >6 letters -5 letters 1 1- letters 7 No chnge Abbrevition: ARMD, ge-relted mculr degenertion. n = ptients, eyes. b The verge improvement of cuity ws 6. letters, nd the verge improvement of contrst ws 5. letters. Abbrevition: ARMD, ge-relted mculr degenertion. Figure 1. ARMD wet: results for visul field expnsion Mrked Moderte No chnge or miniml Abbrevition: ARMD, ge-relted mculr degenertion. ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 Kondrot Vision Prmeters nd Alterntive Therpies

10 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com MACULAR HOLE, WRINKLING, PUCKER Tble 6. Results: Mculr Hole, Wrinkling, Pucker Acuity Improvement Number of Letters Averge cuity chnge. Rnge -11 Contrst Improvement Number of Letters Averge contrst chnge.5 Rnge -8 Figure 1. Mculr hole, wrinkling, pucker: results for visul field expnsion. Visul Field Expnsion Number of Mrked Moderte Miniml n = 9 ptients, 1 eyes. 1 Mrked Moderte Miniml STARGARDT S DISEASE Tble 7. Results: Strgrdt s Disese Figure 15. Strgrdt s disese results for visul field expnsion. Acuity Improvement Number of Letters Averge cuity chnge 6.6 Rnge Contrst Improvement Number of Letters Averge contrst chnge.67 Rnge -1 6 Visul Field Expnsion Number of Mrked 6 n = ptients, 6 eyes. 1 Mrked Moderte Miniml CATARACTS Tble 8. Results: Ctrcts Figure 16. Ctrct: results for visul field expnsion. Acuity Improvement Number of Letters Averge cuity chnge 5.75 Rnge -16 Contrst Improvement Number of Letters Averge contrst chnge. Rnge -6 Visul Field Expnsion Number of Mrked 7 Moderte 1 None to slight Mrked Moderte None to slight n = 6 ptients, 1 eyes. Kondrot Vision Prmeters nd Alterntive Therpies ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 1

11 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com ISCHEMIC OPTIC NERVE Tble 9. Results: Ischemic Optic Neuropthy Acuity Improvement Number of Letters Averge cuity chnge 5.75 Rnge -15 Contrst Improvement Number of Letters Averge contrst chnge.75 Rnge -6 Visul Field Expnsion Number of Mrked Moderte Figure 17. Ischemic optic neuropthy: results for visul field expnsion Mrked Moderte Miniml n = ptients, 6 eyes. RETINITIS PIGMENTOSA Tble 1. Results: Retinitis Pigmentos Acuity Improvement Number of Letters Averge cuity chnge 15. Rnge -68 Figure 18. Retinitis pigmentos: results for visul field expnsion. Contrst Improvement Number of Letters Averge contrst chnge.1 Rnge -8 Visul Fields Expnsion Number of Mrked Moderte Able to see color, previously 1 unble No chnge 1 n = ptients, 8 eyes. 1 Mrked Moderte Able to see color, previously unble 1 1 No chnge DIABETIC RETINOPATHY Tble 11. Results: Dibetic Retinopthy Acuity Improvement Number of Letters Averge cuity chnge 7.8 Rnge -17 Contrst Improvement Number of Letters Averge contrst chnge 5.5 Rnge -11 Visul Field Expnsion Number of Mrked Moderte Figure 19. Dibetic retinopthy: results for visul field expnsion. 1 Mrked Moderte Miniml n = ptients, 6 eyes. ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 Kondrot Vision Prmeters nd Alterntive Therpies

12 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com HISTOPLASMOSIS SCARRING: THE CONDITION Tble 1. Results: Histoplsmosis Retinl Scrring Acuity Improvement Number of Letters Averge cuity chnge Rnge -11 Contrst Improvement Number of Letters Averge contrst chnge 7. Rnge -1 Visul field expnsion Number of Mrked Reduction in blind spots n = ptients, eyes. CONE DYSTROPHY: THE CONDITION Tble 1. Results: Cone Dystrophy Acuity Improvement Number of Letters Averge cuity chnge 5 Rnge -6 Contrst Improvement Number of Letters Averge contrst chnge 1 Rnge - Visul field expnsion Number of Moderte n = 1 ptient, eyes. DISCUSSION Very little reserch hs been done to dte tht hs ttempted to reverse chronic eye disese. One study involved ptients with Strgrdt s mculr dystrophy nd 1 ptient with dry ARMD, who received stem-cell trnsplnts. According to published results in Lncet on Jnury, 1,... it is encourging tht during the observtion period neither ptient lost vision. Best-corrected visul cuity improved from hnd motions to /8 (nd improved from to 5 letters on the Erly Tretment Dibetic Retinopthy Study s [ETDRS ] visul cuity chrt) in the eye of the ptient with Strgrdt s mculr dystrophy, nd vision lso seemed to improve in the ptient with dry ge-relted mculr degenertion. In tht study, 5 letters of improvement ws considered significnt, but the cost of the tretment s well s its risks fr exceeded those of the multifctoril intervention using nturl therpies in the current -dy progrm. Of the current study s prticipnts, 69% hd improvement of t lest 1 line (ie, 5 letters) in cuity, nd 6% hd improvement of t lest 1 line in contrst (Tble ; Figures 1,, nd ). The tretment modlities used were sttisticlly beneficil to ll groups treted improving cuity, contrst, nd visul fields. All tretment modlities re beneficil individully nd hve bsolutely no ssocited pin or discomfort, toxicity, or side effects. This is in significnt contrst to conventionl medicine s tretments tht re either invsive (surgery) or toxic (phrmceuticls) nd produce only short-term remedition without ddressing ny of the underlying custive fctors tht produce eye disese. The tretments used produced the results due to the possible mechnisms of (1) improvement of blood flow, () reduction in inflmmtion, () stimultion of cellulr ctivity, nd/or () stimultion of stem cell ctivity nd regenertion. All of these processes re known to be conducive to tissue, orgn, nd system helth. Further, to fully grsp the significnce of these results, it is importnt to highlight the limittions nd toxicity involved in conventionl tretments for mculr degenertion, glucom, nd ctrcts. ARMD is progressive eye disese tht is becoming more nd more prevlent in the world. There re more thn million new cses per yer in the United Sttes nd Cnd. Currently, more thn million people hve the condition. There re 6 new cses of wet mculr degenertion every dy, mking it significnt problem. Ten thousnd people turn 65 yers old every dy in North Americ. This is the highest risk group for eye conditions tht led to blindness due to ge s well s due to erly life exposure to hevy metls, prior to the bnning of leded gs nd certin toxic pesticides. Conventionl phrmceuticl nd surgicl tretment of both glucom nd mculr degenertion re frught with limittions nd toxic side effects tht mke the cceptnce of nturl, overll helth-improving strtegies, such s those discussed in this rticle, even more compelling. None of the methods used in the -dy progrm hs ny toxic side effects. Eye specilists hve long been wre of the pthologicl chnges tht cn result from the tretment of wet mculr degenertion with nti-vegf (vsculr endothelil growth fctor) injections. Endophthlmitis, which is severe infection tht usully leds to blindness, cn occur, s cn retinl detchment. Glucom s well s ctrcts cn develop. However, there re even more disturbing findings. A recent ntionl study designed to compre the reltive effectiveness of frequently prescribed nti-vegf medictions to tret wet mculr degenertion hd some lrming results when it determined tht, for more thn 18% of those receiving the nti-vegf tretment, the tretment itself ws found to produce retinl geogrphic trophy (GA), which is more severe form of mculr degenertion involving retinl cell deth. The tem of reserchers led by Jun E. Grunwld, MD, of the University of Pennsylvni, hs published study of 1 ptients whose color fundus photos or fluorescein ngiogrms showed no visible signs of GA t enrollment. Kondrot Vision Prmeters nd Alterntive Therpies ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6

13 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com After two yers, the reserchers found tht GA hd developed in 187 ptients, or 18.% of the cohort being studied. They concluded tht nti-vegf therpy my hve role in the development of GA. 17 The phrmceuticl gents used to control glucom cn be expected to produce severl side effects depending on the type of gent used: (1) Prostglndin nlogs: possible chnges in eye color nd eyelid skin, stinging, blurred vision, eye redness, itching, burning. () β-blockers: low blood pressure, reduced pulse rte, ftigue, shortness of breth; rrely: reduced libido, depression. () α-agonists: burning or stinging, ftigue, hedche, drowsiness, dry mouth nd nose, reltively higher likelihood of llergic rection. () Crbonic nhydrse inhibitors: in eye drop form: stinging, burning, eye discomfort; in pill form: tingling hnds nd feet, stomch upset, memory problems, depression, frequent urintion. Some products use combined formuls nd side effects of combined medictions my include ny of the side effects of the drug types they contin. 18 Further, The development of systemic side effects is due to the medictions [being] plced in the eye nd bsorbed into the conjunctivl blood vessels on the eye s surfce. A certin percentge of the ctive ingredient of the mediction, though smll, will enter the bloodstrem nd my dversely ffect functions such s hert rte nd brething. Likewise, some types of eye drops my worsen certin existing medicl conditions such s sthm. Some glucom drugs lso cn interct with other common medictions such s digitlis, prescribed for hert conditions. 19 Ctrct surgery, the long stnding nd most common indeed the only conventionl tretment for ctrcts is not without problems. Ctrct surgery my increse the risk of mculr degenertion, lthough t this time the studies linking mculr degenertion nd ctrct surgery re conflicting. The Bever Dm eye study found s high s -fold increse in mculr degenertion fter ctrct surgery. A study in the Journl of Ophthlmology showed no cler effect but dvised cution. There re severl resons tht my cuse the development of ARMD fter ctrct surgery. The surgicl procedure itself produces shock to the eye, which my result in inflmmtion. The phrmceuticl drops used fter surgery re toxic to the eye. The ging process of the eye is ccelerted due to loss of the humn lens, known to protect ginst ultrviolet light. The lst nd most interesting is the suppressive effect of ctrct surgery. Suppression is homeopthic lw tht sttes tht the humn body hs intelligence, nd tht symptoms nd disese develop to chieve homeostsis or blnce in the body. If the underlying cuse of disese is not treted, more serious disese will develop. A ctrct is symptom of n underlying disese. Surgery does not tret the underlying cuse. The result is more serious disese (ie, mculr degenertion). The 5-yer results of the Bever Dm eye study identified persons with nd without history of ctrct extrction t bseline exmintion nd reexmined them for ARMD t 5 nd 1 yers. They found n ssocition between ctrct surgery nd the 5-yer incidence of lte ARMD: These dt strongly support the pst findings of n ssocition of ctrct surgery with lte A[R]MD independent of other risk fctors, including high-risk genetic sttus, nd suggest the importnce of considering these findings when counseling ptients regrding ctrct surgery. These findings should provide further impetus for the serch for mesures to prevent or dely the development of ge-relted ctrct. 1 Vitmin C deficiency my be cuse of ctrcts, leding to form of focl scurvy in the eye. It hs long been believed tht vitmin C deficiency in one re or tissue of the body mens there is comprble vitmin C deficiency everywhere else. Nothing could be further from the truth. When ctrct develops, the levels of scorbic cid decese in the queous humor tht surrounds nd bthes the lens with nutrients nd oxygen. Might high dosges of vitmin C might reverse ctrcts? If so, this pproch would be preferred to surgery in tht it would correct the underlying conditions rther thn only the mnifesttion of the deficiency. Despite public helth efforts to cut led in gsoline, pint, nd other sources in the environment, led exposure continues to pose significnt problem, wrote resercher Debr A. Schumberg, ScD, MPH, with the preventive medicine division t Brighm nd Women s Hospitl in Boston. In fct, Most dults continue to hve substntil body burdens of led, she wrote in her report. More thn 9% of the totl body burden of led is ccumulted in the bones, where it is stored. Much evidence hs indicted tht ccumulted led exposure increses the risk of severl chronic disorders, including hypertension nd mentl decline. Studies hve lso shown tht led exposure could cuse ge-relted ctrcts, the leding cuse of blindness nd visul impirment worldwide, wrote Schumberg. Schumberg s study involved 6 men ll pproximtely 69 yers old who hd leg bone mesurements indicting led exposure. Reserchers lso looked t the men s medicl records for informtion on eye ctrcts. Men with the highest levels of led in their bones hd more thn.5-fold incresed risk of ctrcts compred with men with the lowest led levels. Led exposure cn dmge eye cells in vriety of wys, leding to protein buildup on the lens nd interfering with clcium bsorption, which keeps the lens cler. Led hs even been found in ctrcts removed from eyes. Bsed on the reserchers estimtes, % of cses of ctrcts in the study were ttributed to led exposure. Mny of the tretment protocols used in this study cn be implemented by generl medicl prctitioners who hve ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 Kondrot Vision Prmeters nd Alterntive Therpies

14 This rticle is protected by copyright. To shre or copy this rticle, plese visit copyright.com. Use ISSN# To subscribe, visit lterntive-therpies.com preventive nd functionl pproch to understnding helth nd disese. With the expected increse in ge-relted vision loss due to both mculr degenertion nd glucom, ntionl movement to rrest or remedite these conditions t erly stges cn prevent millions in the ging popultion from disbility or blindness, nd it cn bring the ssocited socil nd economic benefits to society. Dt re being collected to study the long-term use of these modlities. CONCLUSIONS These tretment protocols should be considered prt of tretment progrm for ll oculr disese process. Eye helth needs to be repositioned within n ssessment of generl helth with the understnding tht, with the exception of congenitl disorders or ccidents, vision decline represents generl diminishment in overll helth nd results directly from toxicity from both externl sources such s ir nd wter, nd the internl ccumultion of toxic metls; poor nutrition; nd other life exposures nd hbits. The metbolism of the eye is such tht this orgn is very likely the first prt of the body to signl overll helth problems. Once this is ccepted, protocol for integrting eye helth ssessment cn become prt of n overll helth evlution rther thn comprtmentlized to specilists, nd preventive strtegies cn be introduced t time when they will be most effective. In this rticle, I demonstrted tht certin nturl interventions given in short period cn reverse eye disese nd improve vision. A long-term study is needed to compre group with these interventions to mtched group with no interventions. AUTHOR DISCLOSURE STATEMENT The uthor received no externl funding for this study. Ptients hd the option to purchse microcurrent mchine, light-therpy equipment, nd/or n ozone genertor fter the progrm, but the resercher hs no finncil interest in the mnufcturing or distribution of the equipment. The purchse option ws offered s convenience to prticipnts. REFERENCES 1. Kondrot EC. Heling the Eye the Nturl Wy: Alterntive Medicine nd Mculr Degenertion. Crson City, NV: Nutritionl Reserch Press; 1.. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Fctors ssocited with ge-relted mculr degenertion: n nlysis of dt from the first Ntionl Helth nd Nutrition Exmintion Survey. Am J Epidemiol. 1988;18(): Kryzhnovskiĭ GN, Lipovetski EM, Kopp OP. Role of the sympthetic nervous system in the pthogenesis of experimentl glucom [in Russin]. Biull Eksp Biol Med. 198;89(5): Pul EL Jr. The tretment of retinl diseses with micro current stimultion nd nutritionl supplementtion. Pper presented t: Interntionl Society for Low- Vision Reserch nd Rehbilittion (ISSLRR) Low Vision Congress; ; Goteborg, Sweden. 5. Michel LD, Allen MJ. Nutritionl supplementtion, electricl stimultion nd ge relted mculr degenertion. J Orthomol Med. 199;8(): Kondrot EC. Ten Essentils to Sve Your Sight. Chrleston, SC: Advntge; Bocci VA. Scientific nd medicl spects of ozone therpy: stte of the rt. Arch Med Res. 6;7(): Nguyen QD, Shh SM, Vn Anden E, Sung JU, Vitle S, Cmpochiro PA. Supplementl oxygen improves dibetic mculr edem: pilot study. Invest Ophthlmol Vis Sci. ;5(): Riv Snseverino E, Meduri RA, Pizzino A, Prnter M, Mrtini E. Effects of oxygen-ozone therpy on ge-relted degenertive retinl mculopthy. Pnminerv Med. 199;(): Cheng N, Vn Hoof H, Bockx E, et l. The effects of electricl currents on ATP genertion, protein synthesis, nd membrne trnsport of rt skin. Clin Orthop Relt Res. 198;(171): Chn HH, Leung MC, So KF. Electrocupuncture provides new pproch to neuroprotection in rts with induced glucom. J Altern Complement Med. 5;11(): Chu TC, Potter DE. Oculr hypotension induced by electrocupuncture. J Ocul Phrmcol Ther. ;18(): Kondrot EC. Initil results of microcurrent stimultion in the tretment of gerelted mculr degenertion. Townsend Lett Doct Ptients. ;(1): Kondrot EC. Microcurrent Stimultion: Mircle Eye Cure? Crson City, NV: Nutritionl Reserch Press; Gottlieb RL, Wllce LB. Syntonic phototherpy. Photomed Lser Surg. 1;8(): Zretsky RB. Introculr pressure of norml nd glucomtous eyes s ffected by ccessory light stimuli. Am J Ophthlmol. 198;1(6): Grunwld JE, Pistilli M, Ying GS, Mguire MG, et l. Comprison of Agerelted Mculr Degenertion Tretments Trils. Ophthlmology. 15 Apr; 1(): Glucom Reserch Foundtion. Glucom medictions nd their side effects. php. Updted July 1, 1. Accessed June 1, Hddrill M. Glucom tretment: eye drops nd other medictions. All About Vision Web site. tretment.htm. Updted Februry 15. Accessed June 1, 15.. Blir CJ, Ferguson J, Jr. Excerbtion of senile mculr degenertion following ctrct extrction. Am J Ophthlmol. 1979;87(1): Klein BE, Howrd KP, Lee KE, et l. The reltionship of ctrct nd ctrct extrction to ge-relted mculr degenertion: the Bever Dm Eye Study. Ophthlmology. 1;119(8): Levy T. Curing the Incurble: Vitmin C, Infectious Diseses, nd Toxins. Phildelphi, PA: Xlibris Corp;.. Schumberg DA, Mendes F, Blrm M, Dn MR, Sprrow D, Hu H. Accumulted led exposure nd risk of ge-relted ctrct in men. JAMA. ;9(): YOUR LAB of CHOICE EXPERTS AT SALIVA, BLOOD SPOT & DRIED URINE TESTING. Lern our full rnge of testing by clling or visiting zrtlb.com/athm Free smple test kit when you get strted Kondrot Vision Prmeters nd Alterntive Therpies ALTERNATIVE THERAPIES, NOV/DEC 15 VOL. 1 NO. 6 5